Trial intelligence / Profile preview

Carnitine in Cardiomyopathy and Myopathy

NCT01904396Phase 4Unknown

Sponsor
University Health Network
Start
Aug 2013
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of levocarnitine in carnitine deficiency, sponsored by University Health Network. Primary endpoint: Serum Carnitine Concentration. Status: unknown.

02

Drugs

levocarnitine
03

Conditions

carnitine deficiency

Beyond the preview

Go deeper on NCT01904396.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01904396.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call